| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0960 | Bff122 | Novel potent and selective inhibitor of kynurenine aminotransferase II |
|
| DC90961 | Bff-816 Featured | Novel, systemically active kynurenine aminotransferase 2 (KAT2) inhibitor, significantly decreased escape latency in the Morris water maze, indicating improved performance in spatial and contextual memorynovel |
|
| DCC0962 | b-gf-15 | Potent inhibitor of centrosomal clustering in malignant cells |
|
| DCC0963 | b-glucogallin | Novel Aldose_reductase_inhibitor>aldose reductase (ALR2) inhibitor |
|
| DCC0964 | Bg-p400-tat | Novel dual inhibitor of norepinephrine transporter (NET) function and thyrointegrin αvβ3 receptor |
|
| DCC0965 | Bgt1-in-9 | The first small-molecule substrate identified with high selectivity for BGT1 over the three other GAT subtypes; M1 muscarinic agonist |
|
| DCC0966 | Bh3i-2 | Cell-permeable apoptosis inducer, specifically preventing BH3 domain-mediated interactions between pro-apoptotic and anti-apoptotic members of the Bcl-2 family |
|
| DCC0967 | Bhq-2-succinimide Ester | Reactive dark quencher used in a variety of Fluorescence Resonance Energy Transfer (FRET) DNA detection probe. |
|
| DCC0968 | Bhq-o-5ht | Novel photoactivatable form of serotonin |
|
| DCC0969 | Bi-0319 | Novel PROTAC (proteolysis-targeting chimera) as a PTK2 protein degerader |
|
| DCC0970 | Bi-1750 Featured | BI-1750 is a highly selective and stable fluorogenic substrate designed for Cathepsin C (CatC), a lysosomal cysteine protease involved in various physiological and pathological processes. Its unique properties make it a powerful tool for studying CatC activity in both research and drug development contexts. |
|
| DCC0971 | Bi-1942 | Novel potent inhibitor of human chymase with >100 fold selectivity against Cathepsin G |
|
| DCC0972 | Bi-2051 | Novel highly selective, soluble and cellular permeable inhibitor of the P. falciparum protease dipeptidyl aminopeptidase 1 (DPAP1) |
|
| DCC0973 | Bi-3257 | Novel inhibitor of HIV replication, preventing the formation of the capsid core structure that encapsulates the viral genome and its associated enzymes, reversing transcriptase and integrase |
|
| DCC0974 | Bi-4659 | Novel potent and selective inhibitor of Alk5 (TGFßR1), blocking the phosphorylation of Smad2 and Smad3 in HaCaT cells |
|
| DCC0975 | Bi-5521 | Novel potent and selective ATP-competitive inhibitor of glycogen synthase kinase (GSK-3), targeting both isoforms GSK-3α and GSK-3β |
|
| DCC0976 | Bi-7273 | Novel highly potent dual inhibitor of BRD9/BRD7 |
|
| DCC0977 | Bi-730357 | Novel RORγ antagonist for the treatment of autoimmune diseases |
|
| DCC0978 | bi-83c11 | Non-ATP competitive inhibitor of JNK, targeting the JNK-JIP interaction |
|
| DCC0979 | Bi-9740 | Novel potent, highly selective, and orally bioavailable CATHEPSIN C (CTSC, CatC) inhibitor |
|
| DCC0980 | Bibs-222 | Novel nonpeptide angiotensin II receptor antagonist |
|
| DCC0981 | Bi-btk-1 | Novel, highly selective and potent irreversible BTK inhibitor |
|
| DCC0982 | Bibx-1382 Dihydrochloride | Potent, selective inhibitor of epidermal growth factor receptor (EGFR) tyrosine kinase |
|
| DCC0983 | Bicifadine | Triple reuptake inhibitor (TRI) |
|
| DCC0984 | Biclofibrate | Antilipidemic agent |
|
| DCC0985 | bicuculline Methobromide | GABAA receptor antagonist |
|
| DCC0986 | Biemamide A | Novel inhibitor of the TGF-β pathway, blocking the epithelial to mesenchymal transition |
|
| DCC0987 | Bifeprunox Mesylate | Partial agonist at dopamine D2 and serotonin 1A receptors |
|
| DCC0988 | Biib028 | Novel selective heat shock protein 90 inhibitor, prodrug of CF2772 |
|
| DCC0989 | Biib-057 | Selective Syk inhibitor |
|
